Totally agree with that last statement as someone working in that industry. Would be nice to not only see public labs gain stable funding, but to see publicly-owned infrastructure for bringing treatments from the lab scale to full production too. For medications at least, this would mean we could get rid of the private sector (or at least provide an alternative option) that didn't inflate the costs of treatments and constantly seek IP that kills treatments that are potentially more effective and/or incredibly cheap to produce and provide to those in need.

The private sector provides a necessary service currently, but only because they have ensured that they have a monopoly. Ultimately, they serve as leeches holding the advancement of medical science back.